The struggle to contain the global threat of superbugs

Tina Reed

January 19, 2023

Antibiotic-resistant superbugs are killing more people each year than HIV and malaria, but progress against them worldwide has largely stalled in the wake of the pandemic.

Why it matters: As COVID-19 made crystal clear, disease doesn’t recognize borders, and one country’s problem can quickly become a global threat…

Read the full article in Axios.

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as…

Putting a face on the ‘invisible threat’ of antimicrobial resistance

Mallory Smith was a young woman who, in her own words, had "big dreams and big goals." When she was…

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Name
First Last
Email
Zipcode
Organization
Title
Name
This field is for validation purposes and should be left unchanged.

Axios

The struggle to contain the global threat of superbugs

Tina Reed

January 19, 2023

More

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Sign up for the latest on fighting AMR